Scholarlink

<p>Organic room-temperature phosphorescent (RTP) and photodynamic therapy (PDT) both rely on triplet excitons generated through intersystem cross-system processes (ISC), but their energy dissipation pathways—the radiative decay of RTP and the reactive oxygen species (ROS) production of photodynamic therapy (PDT) are essentially competitive. Here, we report a photosensitizer based on bromobenzoylpyridine named 2N-Br, which achieves short-lifetime phosphorescence emission (lifetime = 0.018&#xa0;ms, <i>Φ</i>≈0%), but generates a strong ROS. The molecular structure characterized by carbonyl and bromine atoms can effectively promote the efficient ISC process. Theoretical calculations show that it has a narrow ΔE<sub>ST</sub>, while single crystal analysis shows that the dihedral angle (56.03°) and weak intermolecular interaction reduces the restricted molecular movement and enhances the non-radiative transition, which is conducive to the generation of oxygen-dependent ROS. When nanoparticles (2N-Br NPs) were fabricated, this material exhibited a strong PDT effect on 4T1 cells under 405&#xa0;nm Xe lamp exposure. This work established a molecular strategy that links phosphorescence with the generation of ROS, demonstrating that the generation of strong ROS can coexist with ultra-low phosphorescence efficiency.</p> Graphical Abstract <p>In this work, a kind of bromobenzoyl pyridine-based RTP material 2N-Br with photodynamic therapy was successfully prepared. The study of phosphorescence emission and ROS production opens up a new way for the development of novel photodynamic therapeutic materials.</p> <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A Bromobenzoyl Pyridine Photosensitizer with Suppressed Phosphorescence for Efficient ROS-Based Photodynamic Therapy

  • 期刊论文

  • 发表日期：

    2025年7月5日

查看全文
  • Sixu Wang

摘要

Organic room-temperature phosphorescent (RTP) and photodynamic therapy (PDT) both rely on triplet excitons generated through intersystem cross-system processes (ISC), but their energy dissipation pathways—the radiative decay of RTP and the reactive oxygen species (ROS) production of photodynamic therapy (PDT) are essentially competitive. Here, we report a photosensitizer based on bromobenzoylpyridine named 2N-Br, which achieves short-lifetime phosphorescence emission (lifetime = 0.018 ms, Φ≈0%), but generates a strong ROS. The molecular structure characterized by carbonyl and bromine atoms can effectively promote the efficient ISC process. Theoretical calculations show that it has a narrow ΔEST, while single crystal analysis shows that the dihedral angle (56.03°) and weak intermolecular interaction reduces the restricted molecular movement and enhances the non-radiative transition, which is conducive to the generation of oxygen-dependent ROS. When nanoparticles (2N-Br NPs) were fabricated, this material exhibited a strong PDT effect on 4T1 cells under 405 nm Xe lamp exposure. This work established a molecular strategy that links phosphorescence with the generation of ROS, demonstrating that the generation of strong ROS can coexist with ultra-low phosphorescence efficiency.

Graphical Abstract

In this work, a kind of bromobenzoyl pyridine-based RTP material 2N-Br with photodynamic therapy was successfully prepared. The study of phosphorescence emission and ROS production opens up a new way for the development of novel photodynamic therapeutic materials.